Protracted radiotherapy treatment duration in medulloblastoma

American Journal of Clinical Oncology: Cancer Clinical Trials

Volumn 26, Issue 1, 2003, Pages 55-59

  Paulino, Arnold C ^a,b,c   Wen, B Chen ^a   Mayr, Nina A ^a   Tannous, Raymond ^b   Loew, Thomas W ^b   Goldman, Frederick D ^b   Meeks, Sanford L ^a   Ryken, Timothy C ^a   Buatti, John M ^a  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^c EMORY CLINIC   (United States)

Author keywords

Chemotherapy; Medulloblastoma; Posterior fossa control; Radiotherapy; Treatment duration

Indexed keywords

CISPLATIN; CYTARABINE; ETOPOSIDE; IFOSFAMIDE; LOMUSTINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD TOXICITY; BONE MARROW SUPPRESSION; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CEREBROSPINAL FLUID PRESSURE; CHILD; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE DURATION; DOSE RESPONSE; FEMALE; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDULLOBLASTOMA; MULTIVARIATE ANALYSIS; NEUTROPENIA; OUTCOMES RESEARCH; POSTERIOR FOSSA; PROGNOSIS; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CEREBELLAR NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CRANIAL FOSSA, POSTERIOR; CRANIAL IRRADIATION; FEMALE; HUMANS; INFANT; MALE; MEDULLOBLASTOMA; MIDDLE AGED; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 0037320616     PISSN: 02773732     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000421-200302000-00012     Document Type: Article

References (28)

1. Bouffet E, Bernard JL, Frappaz D, et al. M4 protocol for cerebellar medulloblastoma: supratentorial radiotherapy may not be avoided. Int J Radiat Oncol Biol Phys 1992;24:79-85.
2. Jenkin RDT. Medulloblastoma in childhood radiation therapy. Can Med Assoc J 1969;100:51-53.
3. Landberg TG, Lindgren ML, Cavallin-Stahl EK, et al. Improvements in the radiotherapy of medulloblastoma, 1946-1975. Cancer 1980;45:670-678.
4. Bloom HJG, Bessell EM. Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 1990;18:763-772.
5. Silverman CL, Simpson JR. Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure. Int J Radiat Oncol Biol Phys 1983;26:357-362.
6. Tarbell NJ, Loeffler JS, Silver B, et al. The change in patterns of relapse in medulloblastoma. Cancer 1991;68:1600-1604.
7. Carrie C, Alapetite C, Mere P, et al. and the French Medulloblastoma Group. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. Radiother Oncol 1992;24:77-81.
8. Miralbell R, Bleher A, Huguenin P, et al. Pediatric medulloblastoma: radiation treatment technique and patterns of failure. Int J Radiat Oncol Biol Phys 1997;37:523-529.
9. Barton MB, Keane TJ, Gadalla T, et al. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer. Radiother Oncol 1992;23:137-143.
10. Bentzen SM, Johansen LV, Overgaard J, et al. Clinical radiobiology of squamous cell carcinoma of the oropharynx. Int J Radiat Oncol Biol Phys 1991;20:1197-1206.
11. Fowler JF, Tanner MA, Bataini JP, et al. Further analysis of the time factor in squamous cell carcinoma of the tonsillar region. Radiother Oncol 1990;19:237-244.
12. Fyles A, Keane TJ, Barton M, et al. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992;25:273-279.
13. DelCharco JO, Bolek TW, McCollough WM, et al. Medulloblastoma: time-dose relationship based on a 30 year review. Int J Radiat Oncol Biol Phys 1998;42:147-154.
14. Chang CH, Housepian EM, Herbert C. An operative staging system and a megavoltage radiotherapeutic technique for medulloblastoma. Radiology 1969;93:1351-1359.
15. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
16. Paterson E, Farr RF. Cerebellar medulloblastoma treatment of irradiation of whole central nervous system. Acta Radiol 1953;39:323-336.
17. Chan AW, Tarbell NJ, Black PM, et al. Adult medulloblastoma: prognostic factors and patterns of relapse. Neurosurgery 2000;47:623-632.
18. MacManus MP, Clarke J, McCormick D, et al. Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation. Int J Radiat Oncol Biol Phys 1993;26:845-850.
19. Marks LB, Halperin EC. The use of G-CSF during craniospinal irradiation. Int J Radiat Oncol Biol Phys 1993;26:905-906.
20. Chin D, Sklar C, Donahue B, et al. Thyroid dysfunction as a late effect in survivors of pediatric medulloblastoma/primitive neuroectodermal tumors: a comparison of hyperfractionated versus conventional radiotherapy. Cancer 1997;80:798-804.
21. Marymont MH, Geohas J, Tomita J, et al. Hyperfractionated craniospinal radiation in medulloblastoma. Pediatr Neurosurg 1996;24:178-184.
22. Wara WM, Weil MD, Larson DA, et al. Hyperfractionated radiotherapy of medulloblastoma [Abstract]. Int J Radiat Oncol Biol Phys 1999;45(Suppl):212.
23. Bailey CC, Gnekow A, Wellek S, et al. Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Med Pediatr Oncol 1995;25:166-178.
24. Kortmann RD, Kuhl J, Timmermann N, et al. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91. Int J Radiat Oncol Biol Phys 2000;46:269-279.
25. Zeltzer PM, Boyett JM, Finlay JL, et al. Metastasis stage, adjuvant treatment and residual tumor are prognostic factors for medullo-blastoma in children: conclusions from the Children's Cancer Group 921 randomized phase III study. J Clin Oncol 1999;17:832-845.
26. Tait DM, Thornton-Jones H, Bloom HJC, et al. Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). Eur J Cancer 1990;26:464-469.
27. Evans AE, Jenkin RDT, Sposto R, et al. The treatment of medulloblastoma: results of a prospective randomized trial of radiation therapy with and without CCNU, vincristine and prednisone. J Neurosurg 1990;72:572-582.
28. Krischer JP, Ragab AH, Kun L, et al. Nitrogen mustard, vincristine, procarbazine, and prednisone as adjuvant chemotherapy in the treatment of medulloblastoma: a Pediatric Oncology Group study. J Neurosurg 1991;74:905-909.